Patent · US Active

Quinazolinamide derivatives

US8546565B2 · kind B2 · utility

4Cited by

0References

23Claims

0Family size

Assignee

Merck Patentgesellschaft · DE

Inventors

Hans-Michael Eggenweiler · Darmstadt, DE
Christian Sirrenberg · Darmstadt, DE
Hans-Peter Buchstaller · Griesheim, DE

Key dates

Filing date	Nov 12, 2009
Grant date	Oct 1, 2013
Priority date	—
Expiry date	Jul 23, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel quinazolinamide derivatives of the formula (I), in which R1-R5 and X have the meanings indicated in Claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.